Phase 3 Development of Alginate-Organic Denture Fixative Cream by bonyf

bonyf NV announces advancement to Phase 3 in developing its Alginate-Organic Olive-oil based Denture Fixative Cream. This follows a successful clinical study by Dermatest GmbH, confirming the product's efficacy and safety over a five-day application period.

The primary focus was to test the cream's retention and stability, showing significant improvement in masticatory ability with up to 24-hour denture retention. Participants experienced no adverse reactions, indicating high tolerability.

bonyf's CEO, Jean-Pierre Bogaert, highlights the study's success as a milestone. The company plans to expedite market launch, offering a superior denture care solution, emphasizing innovation in oral care.